PERCEPTIVE ADVISORS LLC

Holdings History for Nautilus Biotechnology, Inc. - Common stock, par value $0.0001 per share (NAUT)

Symbol: NAUT on Nasdaq
Investment type: Equity / Common stock, par value $0.0001 per share
Latest Disclosed Shares Owned: 12,815,113 shares
Security Ownership %: 10%

Shares, Excluding Options vs Price

Value, Excluding Options

Perceptive Advisors LLC ownership in Nautilus Biotechnology, Inc. Common stock, par value $0.0001 per share (NAUT)

24 Jun 2025 - Perceptive Advisors LLC has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 12,815,113 shares of Nautilus Biotechnology, Inc. Common stock, par value $0.0001 per share (NAUT). This represents 10% ownership of the company. In their previous filing dated 31 Jan 2025, PERCEPTIVE ADVISORS LLC had reported owning 12,594,211 shares, indicating an increase of +1.8%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Perceptive Advisors LLC	10%	+1%	$11,149,148	12,815,113	+220,902	+1.8%	$0.87	13D/A	20 Jun 2025	24 Jun 2025, 16:42
Perceptive Advisors LLC	10%		$8,941,890	12,594,211			$0.71	13D/A	31 Jan 2025	31 Jan 2025, 21:06

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.45%	0%	$24,558,711	12,594,211	0		$1.95	Q4 2025
30 Sep 2025	0.31%	0%	$10,642,108	12,594,211	0		$0.84	Q3 2025
30 Jun 2025	0.34%	0%	$9,130,802	12,594,211	0		$0.72	Q2 2025
31 Mar 2025	0.38%	0%	$10,843,615	12,594,211	0		$0.86	Q1 2025
31 Dec 2024	0.59%	0%	$21,158,274	12,594,211	0		$1.68	Q4 2024
30 Sep 2024	0.77%	0%	$35,893,501	12,594,211	0		$2.85	Q3 2024
30 Jun 2024	0.71%	0%	$29,470,453	12,594,211	0		$2.34	Q2 2024
31 Mar 2024	0.65%	0%	$37,026,980	12,594,211	0		$2.94	Q1 2024
31 Dec 2023	0.84%	+0.23%	$37,656,690	12,594,211	+3,483,060	+38%	$2.99	Q4 2023
30 Sep 2023	0.97%	0%	$28,791,237	9,111,151	0		$3.16	Q3 2023
30 Jun 2023	1%	0%	$35,260,154	9,111,151	0		$3.87	Q2 2023
31 Mar 2023	0.75%	0%	$25,237,888	9,111,151	0		$2.77	Q1 2023
31 Dec 2022	0.47%	0%	$16,400,071	9,111,151	0		$1.80	Q4 2022
30 Sep 2022	0.56%	0%	$19,315,000	9,111,151	0		$2.12	Q3 2022
30 Jun 2022	0.91%	0%	$24,508,000	9,111,151	0		$2.69	Q2 2022
31 Mar 2022	0.94%	0%	$39,542,000	9,111,151	0		$4.34	Q1 2022
31 Dec 2021	0.83%	+0.02%	$47,195,000	9,111,151	+200,000	+2.2%	$5.18	Q4 2021
30 Sep 2021	0.91%	0%	$54,714,000	8,911,151	0		$6.14	Q3 2021
30 Jun 2021	1.3%	+1.3%	$90,002,000	8,911,151	+8,911,151	NEW	$10.10	Q2 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.